Cerebral malaria is one of the most common causes of non-traumatic encephalopathy. A 25-year-old man who is a known intravenous and oral drug abuser presented to our clinic with fever and sore throat for two days prior and an altered level of consciousness for one day. On examination, the patient was icteric, and his Glasgow coma scale score on arrival was 10/15; he had dilated pupils reactive to light and a positive corneal reflex. All cranial nerves were intact; however, signs of meningeal irritation were positive. Motor examination showed an increased tone and rigidity in all limbs, patellar reflex was 3+, plantars were down-going, and clonus was negative. A fundoscopic examination was unremarkable. Additional investigations revealed he was positive for Plasmodium falciparum, HIV, hepatitis B, and hepatitis C. In addition, a test of his cerebrospinal fluid revealed evidence of cerebral malaria. We initiated artemether 120 mg, intravenous ceftriaxone 2 g, and 5% dextrose saline for the intermittent hypoglycemia. The patient’s condition eventually improved drastically. This case outlines the possible exacerbating effect of HIV on malaria, and it calls for HIV screening and staging alongside suspected malaria. This case also underlines the need for further evaluation of a potential protective role of hepatitis B and C to find an alternative therapeutic cure for malaria.
Malaria is an important parasitic disease, and its neurological complication, cerebral malaria, is one of the most common causes of non-traumatic encephalopathies in the world . One study reported that 20% to 50% of the deaths in Plasmodium falciparum malaria cases were due to the involvement of the central nervous system . We report a unique case of cerebral malaria from P. falciparum in a patient with HIV, hepatitis B, and hepatitis C, and we explore the potential influence of those concomitant infections on the patient’s cerebral malaria.
A 25-year-old man, with no known comorbidities but with a known history of intravenous drug abuse (heroin) from the age of 18, presented with a concern of fever and sore throat lasting two days and an altered level of consciousness lasting one day. According to the patient’s attendant, he was in his usual state of health two days prior when he developed a high-grade fever associated with a sore throat. Furthermore, patient’s attendant mentioned that he was found in an altered state of consciousness along with fecal and urinary incontinence. The patient had no history of trauma to the head as well as no positive history of seizures. There was no significant past medical or surgical history. The patient’s addiction history was positive for heroin, Hashish, and methamphetamine both orally as well as intravenously. On examination, his vital signs on arrival were as follows: blood pressure, 110/60 mmHg (reference, 120/80 mmHg); pulse, 100 bpm (reference, 70 to 100 bpm); respiratory rate, 30 breaths/minute (reference range, 18 to 22); and temperature, 102°F (reference, 98.6°F). Furthermore, in his general physical exam, he was positive for jaundice and had marks of cuts on his forearm, suggesting the possibility of multiple needle insertions. His abdominal, respiratory, and cardiovascular exam results were unremarkable. His Glasgow coma scale (GCS) on arrival was 10/15. He had dilated pupils reactive to light, as well as a positive corneal reflex. All cranial nerves were intact; however, signs of meningeal irritation were present. A motor examination showed an increased tone in all limbs, positive rigidity in all four limbs, his patellar reflex was 3+, his plantars were down-going, and clonus (ankle and knee) was negative. Furthermore, the results of the fundoscopic examination were unremarkable.
We immediately did clinical laboratory testing of this patient. His laboratory test results are presented in Table 1. Given our region, we also tested for malaria and found the patient was positive for Plasmodium falciparum. Given the patient’s intravenous drug abuse, we also tested his viral markers and HIV status, the results of which were positive for both hepatitis B and C and HIV, with a CD4 count of 270 (reference range, 500 to 1500). Immediately, the patient was catheterized with monitoring of urine output, and a nasogastric tube was passed. The patient was started on artemether, 120 mg, delivered in six doses spaced 12 hours apart, and intravenous ceftriaxone 2 g/day for five days. The patient had low random blood glucose levels of 60 mg/dL (reference range, 79 to 160 mg/dL), for which he was started on 5% dextrose saline intravenously as well. At this point, we were suspicious of many differentials such as cerebral malaria, bacterial/tuberculous/fungal meningitis, cytomegalovirus/herpes simplex virus encephalitis, drug overdose, central nervous system (CNS) lymphoma, as well as toxoplasmosis. To arrive at a final diagnosis, we conducted a series of additional investigations. We ordered a chest X-ray and ultrasound of the abdomen, the findings of which were unremarkable. To rule out meningitis, we did a lumbar puncture, and his cerebrospinal fluid (CSF) findings are presented in Table 2. At the time of the lumbar puncture, his random blood glucose level was 102 mg/dL (reference range, 79 to 160 mg/dL). Results of the tests were negative for Cryptococcus antigen and tuberculosis. A computed tomography (CT) scan and magnetic resonance image (MRI) of the brain were unremarkable, thereby ruling out ring-enhancing lesions due to tuberculoma, CNS lymphoma or toxoplasmosis. To rule out infective endocarditis, we tested blood cultures and conducted an echocardiographic exam, the results of which were both unremarkable. We also ordered a urine toxicology test given the patient’s status as a drug addict. The urine toxicology results were negative for any drug intoxication. By this point in our investigation, we became firm in our belief that cerebral malaria was the correct diagnosis.
However, after 10 days of treatment, the patient showed considerable improvement despite being very critical in condition. He was no longer in an altered level of consciousness, and his fever had subsided. Furthermore, his GCS improved to 15/15, and his neurological examination results were normal. His laboratory findings had also improved. The patient was discharged and referred to an HIV clinic and a hepatitis outpatient department for his viral infections; he was also referred to a rehabilitation program for his addiction.
Cerebral malaria is defined as a diffuse encephalopathy with unusual focal neurologic signs. Clinically, the patient is febrile, in an altered level of consciousness with a divergent gaze and a variable tone. There are signs of meningism, but to a lesser degree than meningitis . Furthermore, as there are signs of multi-organ dysfunction, so the assessment of anemia, jaundice, and acidotic breathing is important for the overall prognosis of the patient. Rarely, the patient can also have disseminated intravascular coagulation, along with bleeding from the upper gastrointestinal tract as well as the skin. Furthermore, hypoglycemia is a common finding in about 8% of adults and 20% of children, and it usually does not occur with other signs of hypoglycemia . Hence, frequent monitoring of blood glucose levels is important. On examination, direct ophthalmoscopy shows retinal hemorrhages in 15% of cases, and indirect ophthalmoscopy also reveals hemorrhages in a much higher percentage of the population . The pupillary reactions are usually normal, corneal reflexes are present (except in deep coma), and the range of eye movements are full. However, rarely, palsy of the third cranial nerve can occur, and the gaze is usually dysconjugate. A motor exam usually reveals a variable tone, absent abdominal reflexes, up-going planters, and, rarely, patellar and ankle clonus can be elicited . Furthermore, studies also report that at least one episode of seizures can occur in cases of cerebral malaria, with status epilepticus being uncommon [1,3].
Our patient was also febrile, with an altered level of consciousness and positive signs of meningism. Furthermore, hypoglycemia was also present intermittently and treated via dextrose saline administration accordingly. Our patient also had a dysconjugate gaze, with normal pupillary reflexes and corneal reflexes with a full range of eye movement. However, his fundoscopic examination was normal, and there were no episodes of seizures. In his motor exam, the planters were down going, and we could not appreciate clonus (patellar and ankle). The findings of CSF analyses in cases of cerebral malaria usually reveal characteristically elevated lactate levels, mild pleocytosis (10 to 50 cells/mm3), as well as mild elevations of proteins (up to 200 mg/dL). CSF glucose levels can be low, but this should be checked cautiously as, in cerebral malaria, plasma glucose levels are already on the lower side. Hence, studies have suggested the use of the ratio of CSF glucose to serum glucose for future studies. In our patient, CSF lactate levels could not be assessed, but there was mild pleocytosis and a marked increase in protein levels; glucose levels were normal. This marked increase of proteins and mild pleocytosis can also help differentiate viral encephalitis and bacterial meningitis, respectively [4,5]. Furthermore, CT scans and MRI in patients of cerebral malaria are usually normal or show edema and cortical or subcortical infarcts in the watershed zone in about 15% to 20% of patients . Our patient had an unremarkable CT scan and MRI.
The effects of HIV, hepatitis B, and hepatitis C on cerebral malaria are scarcely documented. To our knowledge, this is the only case to document cerebral malaria with all three viral infections at the same time. Literature reveals that in HIV, the inflammatory immune response in the brain and destruction of the blood-brain barrier causes an increase in the susceptibility and severity of cerebral malaria. Additionally, the poor response to pathogens impairs the body’s ability to remove the malarial infection, thereby increasing the parasitemia and leading to severe anemia . However, for hepatitis B, studies suggest a difference in opinion, with one study stating that a hepatitis B infection may also exacerbate falciparum malaria, thereby increasing the risk of morbidity and mortality , whilst others state it either has no significant effects on cerebral malaria or can have some protective effects [8,9]. As for hepatitis C, a few authors suggest it slows down the emergence of P. falciparum, indicating a potential protective effect .
Overall, the epidemiology of all the co-infections with cerebral malaria has not been profoundly studied, and our case report will raise awareness of this phenomenon. Malaria and HIV should be considered significant public health issues worldwide, with special emphasis on the Karachi, Pakistan region. In addition, future studies involving patients with cerebral malaria should be screened and staged for HIV for more valuable insight about its effect on cerebral malaria. Additional studies are needed for hepatitis B and hepatitis C to determine their effects on cerebral malaria as the data are scarce in the literature. Moreover, if either hepatitis B or C do confer a protective effect, this protective effect should be explored to determine a potential alternative therapeutic remedy for malaria.
- Newton CR, Hien TT, White N: Cerebral malaria. J Neurol Neurosurg Psychiatry. 2000, 69:433-441. 10.1136/jnnp.69.4.433
- Oo MM, Aikawa M, Than T, Aye TM, Myint PT, Igarashi I, Schoene WC: Human cerebral malaria: a pathological study. J Neuropathol Exp Neurol. 1987, 46:223-231. 10.1097/00005072-198703000-00009
- White NJ, Phillips RE, Looareesuwan S, Chanthavanich P, Warrell DA: Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet. 1988, 332:64-66. 10.1016/S0140-6736(88)90002-5
- Jakka SR, Veena S, Atmakuri RM, Eisenhut M: Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis. Cerebrospinal Fluid Res. 2006, 3:8. 10.1186/1743-8454-3-8
- Misra UK, Kalita J, Prabhakar S, Chakravarty A, Kochar D, Nair PP: Cerebral malaria and bacterial meningitis. Ann Indian Acad Neurol. 2011, 14:35-39. 10.4103/0972-2327.83101
- Hochman S, Kim K: The impact of HIV coinfection on cerebral malaria pathogenesis. J Neuroparasitology. 2012, 3:235547.
- Barcus MJ, Hien TT, White NJ, et al.: Short report: hepatitis b infection and severe Plasmodium falciparum malaria in Vietnamese adults. Am J Trop Med Hyg. 2002, 66:140-142. 10.4269/ajtmh.2002.66.140
- Andrade BB, Santos CJN, Camargo LM, et al.: Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS One. 2011, 6:19841. 10.1371/journal.pone.0019841
- Braga WS, Souza RA, Silva EB, Fonseca JC, Tosta CE: Coinfection between hepatitis B virus and malaria: clinical, serologic and immunologic aspects [Article in Portugese]. Rev Soc Bras Med Trop. 2006, 39:27-31. 10.1590/S0037-86822006000100005
- Gasim GI, Adam I: Hepatitis B hepatitis C virus and malaria co-infection. Int J Vaccine Immunizat. 2015, 1:1-10. 10.16966/2470-9948.101
Cerebral Malaria in a Patient with HIV, Hepatitis B, and Hepatitis C
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Civil Hospital Karachi issued approval None. Approved. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Uddin S, Haq A, Haq Z, et al. (May 02, 2018) Cerebral Malaria in a Patient with HIV, Hepatitis B, and Hepatitis C. Cureus 10(5): e2569. doi:10.7759/cureus.2569
Received by Cureus: April 25, 2018
Peer review began: April 27, 2018
Peer review concluded: April 28, 2018
Published: May 02, 2018
© Copyright 2018
Uddin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.